Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study

Abstract

Purpose We conducted a 5-year, double-blind, randomized, placebo-controlled study to determine whether salmon calcitonin nasal spray reduced the risk of new vertebral fractures in postmenopausal women with osteoporosis. Subjects and methods A total of 1,255 postmenopausal women with established osteoporosis were randomly assigned to receive salmon calcitonin nasal spray (100, 200, or 400 IU) or placebo daily. All participants received elemental calcium (1,000 mg) and vitamin D (400 IU) daily. Vertebral fractures were assessed with lateral radiographs of the spine. The primary efficacy endpoint was the risk of new vertebral fractures in the salmon calcitonin nasal spray 200-IU group compared with the placebo group. Results During 5 years, 1,108 participants had at least one follow-up radiograph. A total of 783 women completed 3 years of treatment, and 511 completed 5 years. The 200-IU dose of salmon calcitonin nasal spray significantly reduced the risk of new vertebral fractures by 33% compared with placebo [200 IU: 51 of 287, placebo: 70 of 270, relative risk (RR) = 0.67, 95% confidence interval (CI): 0.47- to 0.97, P = 0.03]. In the 817 women with one to five prevalent vertebral fractures at enrollment, the risk was reduced by 36% (RR = 0.64, 95% CI: 0.43- to 0.96, P = 0.03). The reductions in vertebral fractures in the 100-IU (RR = 0.85, 95% CI: 0.60- to 1.21) and the 400-IU (RR = 0.84, 95% CI: 0.59- to 1.18) groups were not significantly different from placebo. Lumbar spin…

Overview

Integrity signals

Registry

Crossref · 10.1016/s0002-9343(00)00490-3

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 52 references

Research works printed but not linked: 3

  1. Raisz, 1983, Bone metabolism and its hormonal regulation, Triangle, 22, 83
  2. Chambers, 1988, The effect of calcitonin on the osteoclast, Triangle, 27, 53
  3. Gundberg, 1998, Biology, physiology, and clinical chemistry of osteocalcin, J Clin Ligand Assay, 21, 128

Cited by

See all 1,122

Metadata

Authors
Chesnut, C. H., Silverman, S., Andriano, K., Genant, H., Gimona, A., Harris, S., Kiel, D., LeBoff, M., Maricic, M., Miller, P., Moniz, C., Peacock, M., Richardson, P., Watts, N., & Baylink, D.
Affiliations
  • University of Washington (US)
  • University of California, Los Angeles (US)
  • Novartis (United States) (US)
  • University of California, San Francisco (US)
  • Novartis (Switzerland) (CH)
  • Rhode Island Hospital (US)
  • Brigham and Women's Hospital (US)
  • University of Arizona (US)
  • Colorado Center for Bone Research (US)
  • King's College Hospital (GB)
  • Emory Clinic (US)
  • Jerry L. Pettis Memorial VA Medical Center (US)
Corresponding author
Chesnut, Charles H
Venue
The American Journal of Medicine
Publisher
Elsevier BV
Published
2000-09
Volume
109
Issue
4
Pages
267-276
ISSN
0002-9343 (ISSN-L)
OpenAlex
W1992931986
Cited by
1,122
References
52
Citations by year
2026: 6 · 2025: 12 · 2024: 10 · 2023: 15 · 2022: 17 · 2021: 21 · 2020: 23 · 2019: 19 · 2018: 26 · 2017: 16 · 2016: 23 · 2015: 33 · 2014: 31 · 2013: 49 · 2012: 44
FWCI
70.82
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • The American Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
Cedars-Sinai Medical Center
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
Keywords
salmon calcitonin, nasal spray, osteoporosis, postmenopausal women, vertebral fractures, fracture prevention, bone mineral density, bone turnover, calcium and vitamin D supplementation, dose-response relationship, lumbar spine, hip fracture, treatment discontinuation, adverse effects, drug safety, cost-effectiveness, quality of life
MeSH terms
Aged, Analysis of Variance, Calcitonin, Double-Blind Method, Female, Fractures, Spontaneous, Humans, Middle Aged, Nasal Cavity, Reference Values, Bone Density, Osteoporosis, Postmenopausal, Chi-Square Distribution, Spinal Fractures, Treatment Outcome, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. https://app.cochat.ai/papers/10.1016/s0002-9343(00)00490-3
The paper
Chesnut, C. H., Silverman, S., Andriano, K., Genant, H., Gimona, A., Harris, S., Kiel, D., LeBoff, M., Maricic, M., Miller, P., Moniz, C., Peacock, M., Richardson, P., Watts, N., & Baylink, D. (2000). A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. The American Journal of Medicine. https://doi.org/10.1016/s0002-9343(00)00490-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.